These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

133 related items for PubMed ID: 8016852

  • 1. Pharmacological effects and pathological changes induced by the venom of Pseudechis australis in isolated skeletal muscle preparations.
    Chen SZ, Gopalakrishnakone P, Gwee MC.
    Toxicon; 1994 Mar; 32(3):303-15. PubMed ID: 8016852
    [Abstract] [Full Text] [Related]

  • 2. Action of Micrurus dumerilii carinicauda coral snake venom on the mammalian neuromuscular junction.
    Serafim FG, Reali M, Cruz-Höfling MA, Fontana MD.
    Toxicon; 2002 Feb; 40(2):167-74. PubMed ID: 11689238
    [Abstract] [Full Text] [Related]

  • 3. The effects of five phospholipases A2 from the venom of king brown snake, Pseudechis australis, on nerve and muscle.
    Fatehi M, Rowan EG, Harvey AL, Harris JB.
    Toxicon; 1994 Dec; 32(12):1559-72. PubMed ID: 7725325
    [Abstract] [Full Text] [Related]

  • 4. Neuromuscular effects of four phospholipases A2 from the venom of Pseudechis australis, the Australian king brown snake.
    Geh SL, Rowan EG, Harvey AL.
    Toxicon; 1992 Sep; 30(9):1051-7. PubMed ID: 1440642
    [Abstract] [Full Text] [Related]

  • 5. The efficacy of two antivenoms against the in vitro myotoxic effects of black snake (Pseudechis) venoms in the chick biventer cervicis nerve-muscle preparation.
    Ramasamy S, Isbister GK, Hodgson WC.
    Toxicon; 2004 Dec 15; 44(8):837-45. PubMed ID: 15530965
    [Abstract] [Full Text] [Related]

  • 6. Neuromuscular effects of three phospholipases A2 from the venom of the Australian king brown snake Pseudechis australis.
    Rowan EG, Harvey AL, Takasaki C, Tamiya N.
    Toxicon; 1989 Dec 15; 27(5):551-60. PubMed ID: 2749754
    [Abstract] [Full Text] [Related]

  • 7. Neuromuscular activity of Micrurus laticollaris (Squamata: Elapidae) venom in vitro.
    Carbajal-Saucedo A, Floriano RS, Dal Belo CA, Olvera-Rodríguez A, Alagón A, Rodrigues-Simioni L.
    Toxins (Basel); 2014 Jan 17; 6(1):359-70. PubMed ID: 24445448
    [Abstract] [Full Text] [Related]

  • 8. Electrophysiological and ultrastructural analysis of the neuromuscular blockade and miotoxicity induced by the Micrurus nigrocinctus snake venom.
    Goularte FC, da Cruz-Höfling MA, Corrado AP, Rodrigues-Simioni L.
    Acta Physiol Pharmacol Ther Latinoam; 1999 Jan 17; 49(4):290-6. PubMed ID: 10797872
    [Abstract] [Full Text] [Related]

  • 9. Neurotoxic and myotoxic actions of Naja naja kaouthia venom on skeletal muscle in vitro.
    Reali M, Serafim FG, da Cruz-Höfling MA, Fontana MD.
    Toxicon; 2003 May 17; 41(6):657-65. PubMed ID: 12727270
    [Abstract] [Full Text] [Related]

  • 10. Neurotoxicity of Micrurus lemniscatus lemniscatus (South American coralsnake) venom in vertebrate neuromuscular preparations in vitro and neutralization by antivenom.
    Floriano RS, Schezaro-Ramos R, Silva NJ, Bucaretchi F, Rowan EG, Hyslop S.
    Arch Toxicol; 2019 Jul 17; 93(7):2065-2086. PubMed ID: 31123802
    [Abstract] [Full Text] [Related]

  • 11. Differential myotoxic and cytotoxic activities of pre-synaptic neurotoxins from Papuan taipan (Oxyuranus scutellatus) and Irian Jayan death adder (Acanthophis rugosus) venoms.
    Chaisakul J, Parkington HC, Isbister GK, Konstantakopoulos N, Hodgson WC.
    Basic Clin Pharmacol Toxicol; 2013 May 17; 112(5):325-34. PubMed ID: 23311944
    [Abstract] [Full Text] [Related]

  • 12. A pharmacological examination of venoms from three species of death adder (Acanthophis antarcticus, Acanthophis praelongus and Acanthophis pyrrhus).
    Wickramaratna JC, Hodgson WC.
    Toxicon; 2001 May 17; 39(2-3):209-16. PubMed ID: 10978738
    [Abstract] [Full Text] [Related]

  • 13. Screening of snake venoms for neurotoxic and myotoxic effects using simple in vitro preparations from rodents and chicks.
    Harvey AL, Barfaraz A, Thomson E, Faiz A, Preston S, Harris JB.
    Toxicon; 1994 Mar 17; 32(3):257-65. PubMed ID: 8016848
    [Abstract] [Full Text] [Related]

  • 14. Comparison of the in vitro neuromuscular activity of venom from three Australian snakes (Hoplocephalus stephensi, Austrelaps superbus and Notechis scutatus): efficacy of tiger snake antivenom.
    Hodgson WC, Eriksson CO, Alewood PF, Fry BG.
    Clin Exp Pharmacol Physiol; 2003 Mar 17; 30(3):127-32. PubMed ID: 12603339
    [Abstract] [Full Text] [Related]

  • 15. An electrophysiological study on the effects of Pa-1G (a phospholipase A(2)) from the venom of king brown snake, Pseudechis australis, on neuromuscular function.
    Fatehi M, Rowan EG, Harvey AL.
    Toxicon; 2002 Jan 17; 40(1):69-75. PubMed ID: 11602281
    [Abstract] [Full Text] [Related]

  • 16. In vitro neurotoxic effects of Pseudechis spp. venoms: A comparison of avian and murine skeletal muscle preparations.
    Hart AJ, Isbister GK, Hodgson WC.
    Toxicon; 2013 Mar 01; 63():112-5. PubMed ID: 23246581
    [Abstract] [Full Text] [Related]

  • 17. Species differences in the neuromuscular activity of post-synaptic neurotoxins from two Australian black snakes (Pseudechis porphyriacus and Pseudechis colletti).
    Hart AJ, Isbister GK, O'Donnell P, Williamson NA, Hodgson WC.
    Toxicol Lett; 2013 Jun 07; 219(3):262-8. PubMed ID: 23545348
    [Abstract] [Full Text] [Related]

  • 18. Effects of chemical modifications of Pa-11, a phospholipase A2 from the venom of Australian king brown snake (Pseudechis australis), on its biological activities.
    Takasaki C, Sugama A, Yanagita A, Tamiya N, Rowan EG, Harvey AL.
    Toxicon; 1990 Jun 07; 28(1):107-17. PubMed ID: 2109907
    [Abstract] [Full Text] [Related]

  • 19. Presynaptic neuromuscular activity of venom from the brown-headed snake (Glyphodon tristis).
    Kuruppu S, Fry BG, Hodgson WC.
    Toxicon; 2005 Mar 01; 45(3):383-8. PubMed ID: 15683878
    [Abstract] [Full Text] [Related]

  • 20. In vitro neurotoxic and myotoxic effects of the venom from the black whip snake (Demansia papuensis).
    Kuruppu S, Fry BG, Hodgson WC.
    Clin Exp Pharmacol Physiol; 2006 Apr 01; 33(4):364-8. PubMed ID: 16620302
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.